Obesity leads to body processes that can promote cancer growth
the ONA take:
People who are obese are at higher risk for developing cancer, because extra body fat interferes with processes such as hormone cycles and glucose and fat metabolism. Obesity, defined as a body mass index (BMI) of more than 30, is increasing in industrialized countries.
New international studies show that 5.4% of all cancers in women and 1.9% of cancers in men are associated with high BMI, in particular esophageal, bowel, kidney, and pancreatic cancers, and in women, gallbladder, ovarian, uterine cancers, and postmenopausal breast cancer.
Research has shown that abdominal fat significantly increases the risk for several reasons. Hormonally active fatty tissue produces adipose tissue hormones and the changes the balance of sex hormones. Insulin resistance is increased, resulting in overproduction of insulin leading to diabetes.
In addition, chronic inflammatory processes can occur in the region of abdominal fat. All these factors can contribute to increased cell division and can support tumor growth.
On a positive note, the researchers point out that these risks can be minimized by weight loss or maintaining a healthy weight from the outset.
Diet and exercise are also helpful measures. These behaviors can help people avoid many types of cancers.
People who are obese are at higher risk for developing cancer, because extra body fat interferes with processes.
Sign Up for Free e-newsletters
- Hodgkin Lymphoma Survivorship Marked by Periods of Actionable Distress
- Medication, Vaccination Uptake Improved by Involving Pharmacists in Elder Cancer Care
- Molecular Features May Predict Response in Primary Pancreatic Cancer
- Stem Cell Transplantation Superior to Chemotherapy for Relapsed/Refractory DLBCL, Follicular Lymphoma
- Commission Seeks Standardized Adverse Event Assessments in Hematologic Malignancies
- Navigating Prostate Cancer: A Patient's Experience From Diagnosis to Survivor
- Cell Phones and Cancer Risk (Fact Sheet)
- How Likely Are Oncologists to Refer for Palliative Care? Depends on Their Age
- Use of Corticosteroids With PD-1 or PD-L1 Inhibitors Associated With Poorer Outcomes in NSCLC
- Chemoimmunotherapy Increases Survival in Triple-Negative Breast Cancer
- Integrative Medicine in Childhood Cancer: Practices That Can Help Pediatric Patients
- Clinical Characteristics That Increase Risk of Chemotherapy-Induced Febrile Neutropenia Identified
- Dose-Escalation Mitigates Risk of Grade 3/4 Adverse Events With Ruxolitinib for Myelofibrosis
- Counseling Patients on Oral Chemotherapy
- Patients and Caregivers Worry About Cost of Cancer Care
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|